Bruce Allan Steinbaugh

Title: Bruce Allan Steinbaugh: Innovator in Pharmaceutical Chemistry

Introduction

Bruce Allan Steinbaugh is a notable inventor based in Chelsea, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various medical conditions. With a total of 2 patents to his name, Steinbaugh's work has had a meaningful impact on healthcare.

Latest Patents

Steinbaugh's latest patents include innovative research on tricyclic compounds and methods for treating the herpes virus. One of his notable inventions involves bisalkoxyphosphinyl compounds that serve as renin inhibitors. This invention focuses on novel renin-inhibitory peptides that are beneficial for treating conditions such as renin-associated hypertension, congestive heart failure, hyperaldosteronism, glaucoma, and diseases caused by retroviruses, including HTLV-I, -II, and -III. The patents also encompass processes for preparing these peptides, novel intermediates useful in their preparation, and methods for using them in diagnostics to determine the presence of various health conditions.

Career Highlights

Bruce Allan Steinbaugh is associated with Warner-Lambert Company, where he has contributed to groundbreaking research and development in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for patients suffering from serious health issues.

Collaborations

Steinbaugh has collaborated with esteemed colleagues, including Annette M. Doherty and Harriet W. Hamilton, to further enhance the scope and impact of his research.

Conclusion

In summary, Bruce Allan Steinbaugh is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare outcomes.